Reteplase versus Alteplase for Acute Ischemic Stroke

In this trial from China involving 1412 patients with acute ischemic stroke presenting within 4.5 hours, the percentage who had an excellent functional outcome at 90 days was 79.5% with reteplase and 70.4% with alteplase.

​   The New England Journal of Medicine: Search Results in Neurology/Neurosurgery